Raymond Wong
20.08.2023
How can clinical safety and efficacy concerns in stem cell therapy for spinal cord injury be overcome?
Hejrati N, Wong R, Khazaei M, Fehlings M. How can clinical safety and efficacy concerns in stem cell therapy for spinal cord injury be overcome?. Expert Opin Biol Ther 2023; 23:883-899.
20.08.2023How can clinical safety and efficacy concerns in stem cell therapy for spinal cord injury be overcome?
20.08.2023Expert Opin Biol Ther 2023; 23:883-899
Hejrati Nader, Wong Raymond, Khazaei Mohamad, Fehlings Michael G
Weiter
26.05.2023
Clinical trials for neuroregenerative therapies for spinal cord injury: what have we learnt so far?
Wong R, Hejrati N, Fehlings M. Clinical trials for neuroregenerative therapies for spinal cord injury: what have we learnt so far?. Expert Rev Neurother 2023; 23:487-499.
26.05.2023Clinical trials for neuroregenerative therapies for spinal cord injury: what have we learnt so far?
26.05.2023Expert Rev Neurother 2023; 23:487-499
Wong Raymond, Hejrati Nader, Fehlings Michael G
Weiter